MWN105 3

DRUG2 trials

Sponsors

Shanghai Minwei Biotechnology Co., Ltd

Conditions

MASH - Metabolic Dysfunction-Associated SteatohepatitisOverweight , ObesityType 2 Diabetes Mellitus (T2DM)

Phase 1

Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

RecruitingNCT07803809

Shanghai Minwei Biotechnology Co., LtdMASH - Metabolic Dysfunction-Associated Steatohepatitis, Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)

Start: 2026-04-26End: 2027-01-01Target: 36Updated: 2026-09-08

Phase 2

Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

CompletedNCT07804810

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2025-09-03End: 2026-04-16Updated: 2026-09-04